Indiana Allergy and Immunology Society 2026 Conference
The Indiana Allergy and Immunology Society meeting is an opportunity for allergists within Indiana and its surrounding states to meet in-person and hear updates on diseases from four nationally recognized speakers. In addition, it allows the Indiana University Allergy/Immunology fellows to present cases or discussion.
Target Audience
- A/I Physicians
- Fellows-in-Training
- Residents
- Physician Assistants
- Nurse Practitioners
Learning Objectives
Upon completion of this activity, participants should be able to:
- Organize a treatment plan for a patient with food allergy utilizing FDA approved medications
- Identify health disparities in eczema treatment and how best to treat skin of color
- Summarize methods to diagnose alpha-gal allergy and how to treat it
- Identify patients with primary immunodeficiency and discuss when to refer to an academic institution
- Critique fellows’ case presentations of unique cases at Indiana University
Summary
- 4.75 AttendanceAttendance credit.
- 4.75 CECE credit.
- 4.75 CMECME credit.
The information disclosed by the speakers, planning committee, and reviewers was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
Planning Committee
Simran Jutla, MD
Indiana University and Indiana University Health
Relevant Relationships: None
Leena Padhye, MD
Carmel Allergy
Relevant Relationships: None
Craig Sewell, DO
Indiana University Health/Indiana University School of Medicine
Relevant Relationships: CSL Behring (Consultant); Cogent (Other); Grifols (Speaker)
Téa A. Snider, NP
IU Health
Relevant Relationships: None
Regan Cook
Meeting Achievements
Relevant Relationships: None
Cassidee Rosenbaum
Meeting Achievements
Relevant Relationships: None
Kristen Shepard, BS
Meeting Achievements
Relevant Relationships: None
Faculty
Dana Alhaffar, MD
Indiana University School of Medicine
Relevant Relationships: None
Christina E. Ciaccio, MD FAAAAI
The University of Chicago
Relevant Relationships: Clostrabio, DBV, Novartis, Opella (Advisory Board)
John M. Fahrenholz, MD FAAAAI
Vanderbilt Health
Relevant Relationships: Genentech, Novartis (Consultant); Cogent (Research Grant); Sanofi (Speaker)
David R. Stukus, MD FAAAAI
Nationwide Children's Hospital
Relevant Relationships: Sanofi (Advisory Board); Aquestive Therapeutics, Genentech (Consultant); ARS Pharmaceuticals, DBV technologies (Other-PI)
Jonathan Ting, MD
Indiana University
Relevant Relationships: None
Tony H. Tzeng
Indiana University
Relevant Relationships: None
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment. Name of employer and job title.
- Financial interests. All organizations, other than the employer, from which the faculty member receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests. All organizations which support research projects for which the faculty member serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts. All organizations from which the faculty member have received a gift of any amount in the last year.
- Other interests. All interests of the faculty member that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and The Indiana Allergy & Immunology Society. The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 4.75 Contact Hours.
Credit Claiming Period
Credit claiming for this activity will expire at 11:59 pm on August 31, 2027. Requests to claim credit on or after September 1, 2027, will be subject to an administrative fee.
Medium and Method of Physician Participation for a Live Activity
Follow these steps to complete the activity:
- Register for the activity.
- Review the CME Info Page online or in person
- Attend the meeting
- Navigate to the AAAAI webpage for credit claiming
- Enter the attendance code received at the live activity
- Complete the activity evaluation.
- Claim your credits. Enter only the number of credits earned based on your participation in the activity.
- Print or save your certificate.
Questions
Activity-related questions should be directed to [email protected].
Available Credit
- 4.75 AttendanceAttendance credit.
- 4.75 CECE credit.
- 4.75 CMECME credit.

Facebook
X
LinkedIn
Forward